SCHEMBL7424787

SCHEMBL7424787

O=[N+]([O-])[C](F)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
CTSD P07339 1/20 0.53
GPR35 Q9HC97 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
ALPL P05186 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
NCOA1 Q15788 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
TSHR P16473 1/20 0.44
P2RX1 P51575 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3325012 0.82 ALDH1A1 (0.63) ALDH1A1CTSDCYP1A2CYP3A4CYP2D6
SCHEMBL23037578 0.80 TSHR (0.62) ALDH1A1CTSDCYP1A2CYP3A4CYP2D6
SCHEMBL1428895 0.79 ALDH1A1 (0.60) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL4078013 0.79 ALDH1A1 (0.64) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL20987678 0.78 ALDH1A1 (0.63) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL975117 0.77 ALDH1A1 (0.68) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL10613860 0.77 ALDH1A1 (0.68) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL8592467 0.75 ALDH1A1 (0.60) ALDH1A1CTSDGPR35CYP1A2CYP3A4
SCHEMBL29696138 0.75 TSHR (0.67) ALDH1A1CTSDCYP1A2CYP3A4CYP2D6
SCHEMBL436389 0.75 ALDH1A1 (0.66) ALDH1A1CTSDGPR35CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691311-A Methods for coating invasive devices with inhibitors of thrombin BIOGEN, INC. (US) 1997-11-25 US disclosed
EP-0489070-B1 NOVEL INHIBITORS OF THROMBIN BIOGEN INC (US) 1996-04-24 EP disclosed
US-5433940-A Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin BIOGEN, INC. (US) 1995-07-18 US disclosed
US-5196404-A Hirudin mimic, polypeptide, hirulog; bivalirudin FDA Orange book listed patent BIOGEN, INC. (US) 1993-03-23 US disclosed
EP-0489070-A1 NOVEL INHIBITORS OF THROMBIN. BIOGEN INC (US) 1992-06-10 EP disclosed
EP-0482069-A1 COMBINATIONS AND METHODS FOR TREATING OR PREVENTING THROMBOTIC DISEASES BIOGEN, INC. (US) 1992-04-29 EP disclosed
WO-1991002750-A1 NOVEL INHIBITORS OF THROMBIN BIOGEN, INC. (US) 1991-03-07 WO disclosed
WO-1991001142-A1 COMBINATIONS AND METHODS FOR TREATING OR PREVENTING THROMBOTIC DISEASES BIOGEN, INC. (US) 1991-02-07 WO disclosed
WO-1990003391-A1 HIRUDIN PEPTIDES BIOGEN, INC. (US) 1990-04-05 WO disclosed
EP-0333356-A2 Hirudin peptides BIOGEN, INC. (US) 1989-09-20 EP disclosed